Hyaluronidase and rituximab and Lenvatinib Mesylate
Determining the interaction of Hyaluronidase and rituximab and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Rituximab and Hyaluronidase
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronidase and rituximab-Lenvima
- Hyaluronidase and rituximab-Lenvima (14 MG Daily Dose)
- Hyaluronidase and rituximab-Lenvima (18 MG Daily Dose)
- Hyaluronidase and rituximab-Lenvima (20 MG Daily Dose)
- Hyaluronidase and rituximab-Lenvima (24 MG Daily Dose)
- Hyaluronidase and rituximab-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Hyaluronidase and trastuzumab
- Lenvatinib Mesylate-Hyaluronidase injection
- Lenvatinib Mesylate-Hyaluronidase Injection (Human)
- Lenvatinib Mesylate-Hyaluronidase Subcutaneous, Injection
- Lenvatinib Mesylate-Hyate:C
- Lenvatinib Mesylate-Hybrisil